<p>(A) HeLa cells were transfected with siRNA targeting IKKα or control siRNA for 48 h. Then, the cells were treated with an anti-IFNAR neutralizing antibody for 1 h followed by transfection with poly I:C (50 ng/well) for an additional 4 h. HeLa cells were also treated with IFN-β (200 IU/ml) for 15 min as a control to confirm the neutralizing activity of the anti-IFNAR antibody. (B) IFNAR-null U5A cells were transfected with siRNA targeting IKKα or control siRNA for 48 h, and the cells were then further transfected with poly I:C (500 ng/well) for 10 h. Cell extracts were analyzed by immunoblotting. The results are representative of three independent experiments.</p
<p><b>(A)</b> S3-GFP and R4-GFP cells treated with either IFN-α or IFN-λ for 30 minutes. Cell lysate...
<p>U87, human glioma cells were transiently transfected with control-siRNA. Cells were induced with ...
<p>PKCµ siRNA (si-µ) or scrambled siRNA (Scr) were transfected into wild type cDC for 24 h prior to ...
<p>(A, C) HeLa cells were transfected with siRNA targeting IKKα, IKKβ, and IKKγ or control siRNA. Fo...
<p>(A) HeLa cells were transfected with poly I:C at the indicated concentrations for 4 h. (B) HeLa c...
Non-self RNA is recognized by retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), inducing...
<p>(<b>A</b>) pGL-210 was co-transfected with shSTAT1 or shCONr into HeLa cells. At 36 h after trans...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
<p>IKKα, IKKβ, or IKKγ in HeLa (A) and U5A (B) cells were silenced as described above. Then, the cel...
<p>(<b>A</b>) IFNAR1 knockdown abolishes TPT-induced total cellular MHC I expression. On the left pa...
<p>(A, B) A549 cells were co-transfected with siRIG-I, siMDA-5 or siIPS-1 together with siPKR1 or si...
<p>A) Well differentiated primary HBE cells were treated with 50 ng/ml IFN γ and/or 25 µg/ml dsRNA f...
<p>STAT1 (A), STAT3 (B), or STAT5b (C) were knocked down using siRNA in TL-1 cells supplemented with...
<p>(A) NHBE cells were first transfected with either control or RIG-I-, TLR3-, or NLRP3–targeting si...
<p>The IFN-γ resistant cell line (GR17-1) was transfected with each STAT1 expression plasmid and tre...
<p><b>(A)</b> S3-GFP and R4-GFP cells treated with either IFN-α or IFN-λ for 30 minutes. Cell lysate...
<p>U87, human glioma cells were transiently transfected with control-siRNA. Cells were induced with ...
<p>PKCµ siRNA (si-µ) or scrambled siRNA (Scr) were transfected into wild type cDC for 24 h prior to ...
<p>(A, C) HeLa cells were transfected with siRNA targeting IKKα, IKKβ, and IKKγ or control siRNA. Fo...
<p>(A) HeLa cells were transfected with poly I:C at the indicated concentrations for 4 h. (B) HeLa c...
Non-self RNA is recognized by retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), inducing...
<p>(<b>A</b>) pGL-210 was co-transfected with shSTAT1 or shCONr into HeLa cells. At 36 h after trans...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
<p>IKKα, IKKβ, or IKKγ in HeLa (A) and U5A (B) cells were silenced as described above. Then, the cel...
<p>(<b>A</b>) IFNAR1 knockdown abolishes TPT-induced total cellular MHC I expression. On the left pa...
<p>(A, B) A549 cells were co-transfected with siRIG-I, siMDA-5 or siIPS-1 together with siPKR1 or si...
<p>A) Well differentiated primary HBE cells were treated with 50 ng/ml IFN γ and/or 25 µg/ml dsRNA f...
<p>STAT1 (A), STAT3 (B), or STAT5b (C) were knocked down using siRNA in TL-1 cells supplemented with...
<p>(A) NHBE cells were first transfected with either control or RIG-I-, TLR3-, or NLRP3–targeting si...
<p>The IFN-γ resistant cell line (GR17-1) was transfected with each STAT1 expression plasmid and tre...
<p><b>(A)</b> S3-GFP and R4-GFP cells treated with either IFN-α or IFN-λ for 30 minutes. Cell lysate...
<p>U87, human glioma cells were transiently transfected with control-siRNA. Cells were induced with ...
<p>PKCµ siRNA (si-µ) or scrambled siRNA (Scr) were transfected into wild type cDC for 24 h prior to ...